Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

NCT01188811 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

54

Enrollment

FED

Sponsor class

Conditions

Multiple Sclerosis, Chronic Progressive

Interventions

DRUG: lipoic acid
DRUG: Placebo

Sponsor

VA Office of Research and Development

Collaborators

[object Object]